Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
CEO: James A. Rechtin. Company website
Humana Inc. (HUM) trades at $386.00, up 0.38% on the day, as of Sep 20, 2026 12:34 UTC.
Humana Inc. has a market capitalisation of $46.35B, calculated from the live HUM share price and shares outstanding.
HUM trades at a trailing P/E of 36.55, from earnings per share of $10.56 over the last twelve months.
Humana Inc. generated revenue of $145.68B over the trailing twelve months, which puts the stock at 0.32 times sales.
Yes. Humana Inc. pays a dividend yielding 1.29% on the current share price.
HUM has traded between $163.11 and $428.88 over the past 52 weeks, and the last price is 10.0% below that high.
Yes. Humana Inc. keeps 0.88% of revenue as net income over the trailing twelve months.
Wall Street analysts rate HUM Hold, with an average price target of $418.53, 8.4% above the current price.
Humana Inc. is classified under the Healthcare sector and the Medical - Healthcare Plans industry, and is domiciled in US.
James A. Rechtin is the chief executive of Humana Inc., which employs 67,060 people.
QFI Terminal shows HUM with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open HUM in Terminal See plans